Extract from M&A Insights

M&A Insights is our fully-fledged M&A platform for teams operating in the Nordics and DACH countries, enabling clients to identify and qualify opportunities well in advance of any structured process.
Impilo invests in Swedish HIV diagnostics company Cavidi
February 21, 2018

Impilo has invested in a 29% stake in Cavidi AB, an Uppsala-based diagnostics company focused on HIV Viral Load monitoring. Cavidi has developed a new fully automated viral load diagnostic platform. This platform, Ziva™, aims to meet the need for cost-effective monitoring in high-disease burden countries.

ⓘ This story was originally featured in our daily M&A Newsletter - a part of M&A Insights.
Our insights have been covered by: